Source: Eur Respir Rev 2017; 26: 160069



Rating:

Share or cite this content

Citations should be made in the following way:
Fraser R. Millar, Sam M. Janes, Adam Giangreco. Epithelial cell migration as a potential therapeutic target in early lung cancer. Eur Respir Rev 2017; 26: 160069

Member's Comments

No comment yet.

Related content which might interest you: Prognostic and potential therapeutic impact of prostate specific membrane antigen expression in non-small cell lung cancer Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Therapeutic options targeting angiogenesis in nonsmall cell lung cancer Source: Eur Respir Rev 2014; 23: 79-91 Year: 2014 IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer Source: Eur Respir J , 49 (4)  1600711; DOI: 10.1183/13993003.00711-2016 Year: 2017 Diverse effects of PAI-1 proteins on lung and prostate cancer cell invasion Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment Source: Eur Respir J 2002; 20: Suppl. 38, 400s Year: 2002 A low endothelial cell proliferation fraction, a measurement of ongoing angiogenesis, is associated with poor prognosis in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006 Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006 The influence of conventional and targeted chemotherapy on the expression of stem cell markers in lung cancer cell lines Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 New treatment options for nonsmall cell lung cancer and small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 Clinical implication of stem cell markers in N2 positive non-small cell lung cancer Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer Source: Eur Respir J 2002; 19: 557-570 Year: 2002 Exploration of the evidence of cancer stem cells in lung cancer Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 The effect of siRNA on invasion capability of small cell lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Regulatory mechanims of ER-ß of OPN-Integrin interaction in the migration of human lung cancer cells Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 “Scar-cinoma”: viewing the fibrotic lung mesenchymal cell in the context of cancer biology Source: Eur Respir J 2016; 47:1842-1854 Year: 2016 NEUROD1 is highly expressed in extensive disease small cell lung cancer by promoting migration. Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020